Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
02/2013
02/06/2013CN102908526A Drug for treating palpitation
02/06/2013CN102908523A Traditional Chinese medicine composition for treating haemorrhoids
02/06/2013CN102908513A Application of traditional Chinese medicine composition in medicine for treating arrhythmia
02/06/2013CN102908506A Preparation method of tranquilizer pills mainly containing cinnabar root poria for treating palpitation and insomnia
02/06/2013CN102908453A Double-tonifying pills
02/06/2013CN102908425A Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine
02/06/2013CN102908424A Preparation method of hemiplegia-treating medicine pine needle and silktree albizia bark wine
02/06/2013CN102908402A Medicament for functional shoe for recuperating heart diseases
02/06/2013CN102908389A Medicinal preparation for functional shoes for regulating hypertension
02/06/2013CN102908371A Method for preparing high-purity ferulic acid from angelica sinensis
02/06/2013CN102908364A Mesenchymal stem cell injection, as well as preparation method and application in preparing medicament for treating children dilated cardiomyopathy
02/06/2013CN102908363A Deproteinized calf blood extract and preparation process thereof
02/06/2013CN102908355A Medicinal composition and application thereof
02/06/2013CN102908352A Application of terazosin or its salt in preparing drug for treating septicemia/stroke
02/06/2013CN102908343A Composition capable of lowering blood fat and improving high density lipoprotein cholesterol and preparation method
02/06/2013CN102908338A Preparation method of resveratrol microcapsule
02/06/2013CN102908327A Sustained release preparation for ivabradine or medicinal salt thereof
02/06/2013CN102908305A Dronedarone hydrochloride-containing oral solid medicinal composition and preparation method thereof
02/06/2013CN102603627B Naphthlamide derivative used as protein kinase inhibitor and histone deacetylase inhibitor and preparation method of naphthlamide derivative
02/06/2013CN102443530B Ginseng wolfberry health promotion wine
02/06/2013CN102397264B Method for preparing sinomenine hydrochloride sustained-release tablet
02/06/2013CN102389439B Application of Valvate Kiwifruit glycoside E and Valvate Kiwifruit glycoside F in preparation of medicaments for resisting myocardial ischemia
02/06/2013CN102370646B Substance for protecting heart
02/06/2013CN102250214B Polypeptide for resisting rheumatoid arthritis and application of polypeptide in pharmacy
02/06/2013CN102210717B Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains
02/06/2013CN102146074B Preparation method of pyrrole derivative and application thereof
02/06/2013CN101797273B Method for extracting total flavonoid glycoside from ginkgo leaves
02/06/2013CN101743001B Combination anticoagulant therapy with a compound that acts as a factor XA inhibitor
02/06/2013CN101712672B Novel compound for treating diseases of cardiovascular and cerebrovascular systems, preparation method and application thereof
02/06/2013CN101336689B Caiguosu food and production method thereof
02/05/2013US8367848 Process for the preparation of amorphous calcium salt of atorvastatin
02/05/2013US8367725 Composition and/or method for preventing onset and/or recurrence of cardiovascular events
02/05/2013US8367685 Stable pharmaceutical compositions comprising a pyrimidine-sulfamide
02/05/2013US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
02/05/2013US8367659 Oxazinyl isoflavonoid compounds, medicaments and use
02/05/2013US8367604 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof
02/05/2013CA2557766C Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
02/05/2013CA2557320C Fused heterocyclic derivatives for prevention or treatment of hyperglycemia
02/05/2013CA2492273C 3, 10, and 12a substituted tetracycline compounds
02/05/2013CA2485116C Use of epa and dha in secondary prevention
02/05/2013CA2479555C Use of cocoa flavanols and oligomers thereof to treat cognitive dysfunction and improve cognitive function in neuro-compromised patients
02/05/2013CA2428176C Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
01/2013
01/31/2013WO2013016148A2 Natriuretic peptide compositions and methods of preparation
01/31/2013WO2013014629A1 Pharmaceutical compositions comprising pyrrole diones and their use to inhibit angiogenesis
01/31/2013WO2013014480A1 Process for preparation of dronedarone using amide intermediary compound
01/31/2013WO2013014263A1 Levomilnacipran drug for functional rehabilitation after an acute neurological stroke
01/31/2013WO2013014205A1 Substituted 3 - (thiazole - 4 - carbonyl) - or 3 - (thiazole - 2 - carbonyl) aminopropionic acid derivatives and their use as pharmaceuticals
01/31/2013WO2013014204A2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
01/31/2013WO2013014038A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
01/31/2013WO2013013609A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof
01/31/2013WO2013013503A1 2,3-dihydroimidazo[1,2-c] pyrimidin-5(1h)-one compounds use as lp-pla2 inhibitors
01/31/2013WO2013013273A1 Modulators of protease activated receptors
01/31/2013WO2012146736A4 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
01/31/2013WO2012143416A3 7 - (3,5 - dimethyl - 4 - isoxazolyl) - 8 - (methyloxy) - 1h - imidazo [4,5 -c] quinoline derivatives
01/31/2013US20130030057 METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
01/31/2013US20130030051 Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
01/31/2013US20130030048 Composition for inducing multiple nuclear division of cells
01/31/2013US20130030047 Fatty Acid Derivatives of Catechins and Methods of Their use
01/31/2013US20130030033 4-trimethylammonio-butyrates as cpt2 inhibitors
01/31/2013US20130030024 Method of Administering Pirfenidone Therapy
01/31/2013US20130030023 Orally bioavailable dabigatran prodrugs for the treatment of diseases
01/31/2013US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
01/31/2013US20130030012 Compounds
01/31/2013US20130030008 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
01/31/2013US20130030000 Pharmaceutical compositions for the treatment of pain and other indications
01/31/2013US20130029999 Myosin light chain kinase inhibitor compounds, compositions and related methods of use
01/31/2013US20130029996 Special composition for the use thereof as a drug
01/31/2013US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
01/31/2013US20130029994 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
01/31/2013US20130029985 Novel Compounds
01/31/2013US20130029979 Fused bicyclic compound
01/31/2013US20130029971 Cxcr3 receptor antagonists
01/31/2013US20130029968 Indazoles
01/31/2013US20130029966 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof
01/31/2013US20130029963 1,2,4-triazine-4-amine derivatives
01/31/2013US20130029962 Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
01/31/2013US20130029961 Substituted Heterocyclic Aza Compounds
01/31/2013US20130029950 Methods and compositions for the treatment of proliferative vascular disorders
01/31/2013US20130029948 Heterocyclic autotaxin inhibitors and uses thereof
01/31/2013US20130029946 Dissolution of arterial plaque
01/31/2013US20130029944 Inhibitors of protein kinases
01/31/2013US20130029939 Novel glucokinase activators and methods of using same
01/31/2013US20130028993 Composition and Manufacturing Processes of a Toxicity Free Botanical Drug for Curative Treatment of Chronic Diseases
01/31/2013US20130028968 Compositions and methods to relieve chronic diseases symptoms
01/31/2013US20130028955 Sustained release oral matrix and methods of making thereof
01/31/2013US20130028942 Aerosolized nitrite and nitric oxide-donating compounds and uses thereof
01/31/2013US20130028938 Solid pharmaceutical dosage form
01/31/2013US20130028923 Kdr peptides and vaccines comprising the same
01/31/2013US20130028921 Composition comprising coumestrol or a bean extract containing coumestrol
01/31/2013US20130028920 Stabilized antibody preparations and uses thereof
01/31/2013US20130028883 Treatment of ischemic episodes and cerebroprotection through Misoprostol
01/31/2013US20130028874 Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system
01/31/2013US20130028873 Method for increasing activity in human stem cell
01/31/2013US20130028870 Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
01/31/2013US20130028868 Clinical applications of a recombinant human endostatin adenovirus (e10a) injection
01/31/2013US20130028849 Agent For Stimulating The Expression of Loxl
01/31/2013CA2843037A1 Levomilnacipran drug for functional rehabilitation after an acute neurological stroke
01/31/2013CA2842965A1 2,3-dihydroimidazo[1,2-c] pyrimidin-5(1h)-one compounds use as lp-pla2 inhibitors
01/31/2013CA2842730A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof
01/31/2013CA2841911A1 Substituted 3 - (thiazole - 4 - carbonyl) - or 3 - (thiazole - 2 - carbonyl) - aminopropionic acid derivatives and their use as pharmaceuticals